Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 8, 2017New England Journal of MedicineOpen Access

Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation

View Full Paper
Ask AI
Bookmark
Share

Authors

RLR. Coleman LindsleyHarvard UniversityWSWael SaberMedical College of WisconsinBMBrenton G. MarBroad Institute

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lindsley et al. (2017) studied this question.

synapsesocial.com/papers/69d7573ab54ccf0cfef30e86https://doi.org/10.1056/nejmoa1611604
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome2004 · 676 citations
  2. 2Gain-of-function mutations of PPM1D/Wip1 impair the p53-dependent G1 checkpoint2013 · 177 citations
  3. 3Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission2014 · 717 citations
  4. 4Results of a Phase III Randomized, Multi-Center Study of Allogeneic Stem Cell Transplantation after High Versus Reduced Intensity Conditioning in Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 09012015 · 78 citations
  5. 5Acute myeloid leukemia ontogeny is defined by distinct somatic mutations2014 · 1,003 citations